Inpatient administration of complement inhibitors as rapid-acting therapy for recurrent or refractory myasthenic exacerbation: A case series, review of the literature, and discussion of pathophysiology

Journal of Neuroimmunology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles